Boston — Attorney General Andrea Joy Campbell issued a statement in response to the Supreme Court's ruling in Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine, which upheld access to mifepristone, an FDA-approved medication used for abortion.
"I commend the Supreme Court for unanimously rejecting this lawsuit which is a right-wing, anti-science attack on the FDA and its approval of mifepristone. Mifepristone is safe, effective, and will continue to remain available as it always has been. But make no mistake: anti-abortion advocates will not stop trying to prevent Americans from accessing reproductive healthcare, including medication abortion. I am ready to take on these fights and will use every tool at my disposal to ensure continued access to abortion for all who need it," said AG Campbell.
In 2023, AG Campbell joined a coalition of attorneys general in filing an amicus brief urging the Supreme Court to reverse a Fifth Circuit decision that would have reinstated restrictions on mifepristone. In 2024, she joined the same coalition in filing another amicus brief supporting the FDA’s efforts to reverse a ruling by the U.S. Court of Appeals for the Fifth Circuit that reinstated certain restrictions on mifepristone.
During her tenure, AG Campbell has worked to ensure Massachusetts remains supportive of reproductive justice. Early in her term, she announced the creation of the Abortion Legal Hotline, offering free and confidential legal advice related to abortion access and care. Additionally, she established a Reproductive Justice Unit focused on expanding access to reproductive and gender-affirming care, addressing maternal health disparities, combating misinformation that hinders access to care, collaborating across state lines against national attacks on reproductive health care, and defending Massachusetts’ legal protections for reproductive rights.
The Supreme Court's decision concluded that the plaintiffs lacked standing to challenge the FDA’s regulation of mifepristone.
###